We have also previously detected that Smad3 mediates cardiac and renal fibrosis and inflammation in hypertensive heart disease and diabetic nephropathy by up‐regulating miR‐21 while down‐regulating miR‐29b.21, 22, 23. Here, SMAD3 is linked to hypertensive heart disease.